Filing Flows › Tactile Systems Technology (TCMD) › Q3 2026 › vs Q3 2025
Tactile Systems Technology (TCMD) Q3 2026 vs Q3 2025 (year over year)
Tactile Systems Technology's revenue rose $6.1M (+7%) from $85.8M in Q3 2025 to $91.9M in Q3 2026. The biggest changes: Lymphedema products +$9.5M (+13%); Airway clearance products −$3.4M (-25%). Gross margin 76.7% against 75.8% (+0.9 pts).
Tactile Systems Technology, Q3 2026: revenue $91.9M (+7% year over year), operating margin 10.4%, net earnings $7.2M, operating cash flow $12.0M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 76.7% | 75.8% | +0.9 pts |
| Operating margin | 10.4% | 12.8% | -2.3 pts |
| Net margin | 7.8% | 9.6% | -1.8 pts |
| Free cash flow margin | 12.4% | 10.8% | +1.7 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Lymphedema products | $81.8M | $72.4M | $9.5M | +13% |
| Airway clearance products | $10.0M | $13.4M | −$3.4M | -25% |
| Revenue | $91.9M | $85.8M | $6.1M | +7% |
| Gross profit | $70.5M | $65.0M | $5.5M | +8% |
| Cost of revenue | $21.4M | $20.8M | $615K | +3% |
| Other income, net | $540K | $474K | $66K | +14% |
| Operating profit | $9.6M | $11.0M | −$1.4M | -13% |
| Operating expenses | $60.9M | $54.0M | $6.9M | +13% |
| Pre-tax earnings | $10.1M | $11.4M | −$1.3M | -11% |
| Research & development | $2.5M | $2.2M | $315K | +14% |
| Sales & marketing | $33.0M | $29.8M | $3.2M | +11% |
| General & admin | $24.7M | $21.4M | $3.2M | +15% |
| Other operating costs | $693K | $596K | $97K | +16% |
| Net earnings | $7.2M | $8.2M | −$1.0M | -13% |
| Income tax | $3.0M | $3.2M | −$257K | -8% |
| Depreciation & amortization | $1.8M | $1.6M | $135K | +8% |
| Share-based compensation | $2.4M | $1.8M | $562K | +31% |
| Working capital & other | $669K | −$1.3M | $2.0M | — |
| Operating cash flow | $12.0M | $10.3M | $1.6M | +16% |
| Free cash flow (OCF − capex) | $11.4M | $9.2M | $2.2M | +24% |
| Capital expenditures | $553K | $1.1M | −$569K | -51% |
Questions
How much did Tactile Systems Technology's revenue grow year over year in Q3 2026?
Tactile Systems Technology's revenue rose $6.1M (+7%) from $85.8M in Q3 2025 to $91.9M in Q3 2026.
What drove Tactile Systems Technology's revenue change in Q3 2026?
Lymphedema products +$9.5M (+13%); Airway clearance products −$3.4M (-25%).